Reva touts first implant of bioresorbable scaffold in Turkey

Reva Medical (ASX:RVA) said today that the company launched its Fantom bioresorbable scaffold in Turkey.

There are nearly 100 hospitals performing cardiac catheterizations in Istanbul, according to Reva. The San Diego, Calif.-based company highlighted Turkey as an important market for bioresorbable technologies, noting that it has a commercial distribution deal in the country with Kardionet Healthcare and Foreign Trading.

Get the full story at our sister site, Drug Delivery Business News.

The post Reva touts first implant of bioresorbable scaffold in Turkey appeared first on MassDevice.

from MassDevice https://ift.tt/2rKV5HP